Frost & Sullivan white paper concludes that MUSICA image processing software constitutes a key competitive advantage, enabling Agfa HealthCare DR customers to generate excellent images at a significantly lower dose than current DR competitors while increasing productivity
Frost & Sullivan white paper indicates that Agfa HealthCare’s DR system addresses “The Three Pillars of Digital Radiography’s Value Proposition” - Agfa HealthCare’s image processing software, MUSICA, is highlighted as a key competitive differentiator for Agfa HealthCare - Agfa HealthCare customers indicate that the ability for Agfa HealthCare’s DR system to produce excellent image quality at significantly lower radiation doses while still increasing productivity were key factors in their purchasing decisions
In a white paper titled,“Raising the Bar by Lowering the Dose,” Frost & Sullivan has concluded that Agfa HealthCare’s direct radiography (DR) platform, highlighted by Agfa HealthCare’s MUSICA image processing software, is “well differentiated” from the competition and meets “best-of-breed” status by addressing “The Three Pillars of Digital Radiography’s Value Proposition:” producing excellent image quality, keeping radiation dose as low as reasonably achievable, and enabling high workflow productivity.
In its analysis of the radiography industry and Agfa HealthCare’s DR platform, Frost & Sullivan determined that the true differentiator in imaging today is the sophisticated software that makes a DR system better able to meet the complex demands of users. Agfa HealthCare’s MUSICA image processing software is cited as a leader in the industry for its ability to deliver excellent images at up to 60 percent lower radiation dose• compared to conventional CR/DR, and according to the study, up to 40 percent lower than current DR competitors. In addition, MUSICA’s use of fractional multi-scaled processing results in high-resolution images with sharp detail and high contrast, which increase an interpreter’s diagnostic confidence.
The strength of MUSICA was one of several advantages cited by Agfa HealthCare customers, who were queried on their rationale for selecting Agfa HealthCare’s DR system and the benefits that the platform offers. In interviews conducted by Frost & Sullivan, technologists from health systems across the U.S. noted that the image quality produced by Agfa HealthCare’s DR system and its ability to impact workflow and radiation dose were the leading reasons why they purchased Agfa HealthCare’s DR systems over those of competitors.
Louis Kuitenbrouwer, Vice President Imaging Division, Agfa HealthCare commented,“Agfa HealthCare’s DR technologies were designed with our customers’ needs in mind. We’re excited that our DR systems are continually rated as top products for image quality with sharp details. As noted in the Frost & Sullivan white paper, achieving high image quality while enabling dose optimization and productivity enhancements is the ‘three-pronged key to success for hospital radiography services.’ We can confidently say that our DR technologies offer high resolution, quality images at the lowest radiation dose reasonably achievable, which according to our customers translates into significant workflow benefits.”
*Testing with board-certified radiologists has determined that Cesium Bromide (CR) and Cesium Iodide (DR) Detectors, when used with MUSICA image processing, can provide dose reductions between 50 to 60%, compared to traditional Barium Fluoro Bromide CR systems. Contact Agfa HealthCare for more details.
Contact: Miriam Ladin - Marketing Communications Director - North America
T:+1 401-604-22 03 / F:+1 401-596-8562 - E: miriam.ladin[.]agfa.com.